Private company

Renovacor, Inc.

American biological products company, incorporated in Delaware1

In its 2022 annual report the company says: “We are a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. Our initial focus is on the treatment of BCL2-associated athanogene 3 ( BAG3) mutation - associated dilated cardiomyopathy.”45 It is headquartered in Cambridge, Massachusetts.1

Last updated Oct 20, 2026.

Overview

  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersCambridge, Massachusetts1
  • Incorporated inDE2
  • Business address201 Broadway, Suite 310, Cambridge, Ma 021392
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income34-$18.6M in 2021+3582400% since 2019
-$20.0M-$15.0M-$10.0M-$5.0M02019: -$520-$52020192020: -$3.2M-$3.2M2020+621054%2021: -$18.6M-$18.6M2021+477%
Net income34-$14.1M in 2021+2711631% since 2019
-$15.0M-$10.0M-$5.0M02019: -$520-$52020192020: -$3.2M-$3.2M2020+621054%2021: -$14.1M-$14.1M2021+337%
Fiscal year20182019202020212022
Research and development$2.4M4$11.8M4
Operating income-$5203-$3.2M4-$18.6M4
Net income-$5203-$3.2M4-$14.1M4

Compare Renovacor, Inc. with another company

Corporate structure

Renovacor, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Renovacor, Inc.

  • RTW INVESTMENTS, LP Filed SC 13D/A on Renovacor, Inc., latest Apr 5, 2023 (3 filings since Feb 14, 2022)
  • CITADEL ADVISORS LLC Filed SC 13G/A on Renovacor, Inc., latest Feb 14, 2023 (2 filings since Feb 14, 2022)
  • Altium Capital Management LLC Filed SC 13G on Renovacor, Inc., latest Feb 14, 2022
  • PERISCOPE CAPITAL INC. Filed SC 13G/A on Renovacor, Inc., latest Feb 14, 2022
  • Steven Michael Oliveira Filed SC 13G/A on Renovacor, Inc., latest Jan 19, 2022
  • K2 PRINCIPAL FUND, L.P. Filed SC 13G/A on Renovacor, Inc., latest Jan 18, 2022
  • Renovacor, Inc. Cambridge, Massachusetts

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Renovacor, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$380.0K4 Dec 31, 2021$3.0K4 Dec 31, 2020+12566.7%
Accumulated depreciation$1.0K4 Dec 31, 2021$2.0K4 Dec 31, 2020−50.0%
Property and equipment, net$379.0K4 Dec 31, 2021$1.0K4 Dec 31, 2020+37800.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$78.8M4 Dec 31, 2021$5.4M4 Dec 31, 2020+1363.4%
Marketable securities, non-current$86.2M3 Dec 31, 2020

Leadership

Who has led Renovacor, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Magdalene Cook2021–2022

Chair

  1. Gbolahan Amusa2020

Chief financial officer

  1. George Kaufman2020
  2. Wendy F. Dicicco2021–2022
  3. Frederick W. Driscoll2022

Chief operating officer

  1. Guy Barudin2020
2025
Board members and other officers (14)

Former names

  • Chardan Healthcare Acquisition 2 Corp.Mar 9, 2020 to Sep 3, 20212
  • Chardan Healthcare Acquisition III Corp.Jan 16, 2020 to Jan 16, 20202

Timeline

  1. Dec 1, 20228-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights25
  2. Oct 14, 20228-K Regulation FD disclosure26
  3. Sep 22, 20228-K Regulation FD disclosure27
  4. Sep 20, 20228-K Entered a material agreement; Other events28
  5. Aug 8, 20228-K Results of operations29
  6. Jul 12, 20228-K Regulation FD disclosure30
  7. Jun 24, 20228-K Executive or director change31
  8. Jun 3, 20228-K Executive or director change32
  9. Jun 1, 20228-K Other events33
  10. May 26, 20228-K Shareholder vote34
  11. May 12, 20228-K Results of operations35
  12. Mar 28, 20228-K Executive or director change36
  13. Sep 8, 2021New chief executive Magdalene Cook becomes CEO7

Calendar

When it reported results

  1. Aug 8, 2022Reported quarterly or annual results29
  2. May 12, 2022Reported quarterly or annual results35
  3. Mar 24, 2022Reported quarterly or annual results37
  4. Nov 15, 2021Reported quarterly or annual results38

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

107 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 16 major events, 42 insider forms, 9 large holders, 35 other. The latest 20:

  1. Apr 5, 2023SC 13D/A RENOVACOR, INC. EDGAR
  2. Apr 5, 20234 EDGAR
  3. Feb 14, 2023SC 13G/A EDGAR
  4. Dec 12, 202215-12G EDGAR
  5. Dec 5, 2022EFFECT EDGAR
  6. Dec 5, 2022EFFECT EDGAR
  7. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  8. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  9. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  10. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  11. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  12. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  13. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  14. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  15. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  16. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  17. Dec 5, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  18. Dec 1, 20228-K EDGAR
  19. Dec 1, 2022S-8 POS EDGAR
  20. Dec 1, 2022S-8 POS EDGAR

The 107 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

24 open-market trades by officers, directors and large owners since October 2021: 24 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 18, 2022RTW INVESTMENTS, LP10% ownerBuy44,440$8.00$355.5KForm 4
Jan 14, 2022WONG RODERICK10% ownerBuy150,723$8.00$1.2MForm 4
Jan 13, 2022WONG RODERICK10% ownerBuy286$7.75$2.2KForm 4
Jan 12, 2022WONG RODERICK10% ownerBuy1,950$7.67$15.0KForm 4
Jan 6, 2022RTW INVESTMENTS, LP10% ownerBuy51,296$8.00$410.4KForm 4
Jan 5, 2022RTW INVESTMENTS, LP10% ownerBuy100,195$8.00$801.6KForm 4
Jan 4, 2022RTW INVESTMENTS, LP10% ownerBuy4$8.00$31Form 4
Jan 3, 2022RTW INVESTMENTS, LP10% ownerBuy441$7.95$3.5KForm 4
Dec 30, 2021RTW INVESTMENTS, LP10% ownerBuy3,743$8.00$29.9KForm 4
Dec 29, 2021RTW INVESTMENTS, LP10% ownerBuy479$8.00$3.8KForm 4
Dec 27, 2021WONG RODERICK10% ownerBuy4,905$7.99$39.2KForm 4
Dec 23, 2021WONG RODERICK10% ownerBuy61,584$7.97$490.8KForm 4
Dec 22, 2021WONG RODERICK10% ownerBuy3,500$7.95$27.8KForm 4
Dec 21, 2021WONG RODERICK10% ownerBuy5,473$8.00$43.8KForm 4
Dec 20, 2021WONG RODERICK10% ownerBuy130,316$7.96$1.0MForm 4
Nov 17, 2021RTW MASTER FUND, LTD.10% ownerBuy21,161$9.00$190.4KForm 4
Nov 16, 2021RTW MASTER FUND, LTD.10% ownerBuy42,410$9.00$381.7KForm 4
Nov 15, 2021RTW MASTER FUND, LTD.10% ownerBuy4,320$9.01$38.9KForm 4
Nov 12, 2021RTW MASTER FUND, LTD.10% ownerBuy631$8.50$5.4KForm 4
Nov 11, 2021RTW MASTER FUND, LTD.10% ownerBuy319$8.44$2.7KForm 4

All 24 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Renovacor, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARRenovacor, Inc.1
  • CIK0001799850
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)1
  • Business address201 Broadway, Suite 310, Cambridge, MA 021391
  • Phone610-424-26501
  • Shares outstanding17,269,415 as of Nov 10, 20226
  • Public float$85.9M as of Jun 30, 20214
  • On EDGAR sinceJan 16, 20201
  • Filings194 in all: 4 (50), 8-K (23), 3 (22), 424B3 (14), DEFA14A (10), 10-Q (9), 425 (9), SC 13G (7)1
    All 33 form types

    SC 13G/A (7), EFFECT (4), UPLOAD (4), CORRESP (3), 10-K (2), 25-NSE (2), DEFM14A (2), NT 10-Q (2), POS AM (2), PRER14A (2), S-1 (2), S-1/A (2), S-8 (2), S-8 POS (2), SC 13D (2), 15-12G (1), 424B4 (1), 8-A12B (1), 8-A12B/A (1), 8-K/A (1), CERT (1), DEF 14A (1), DRS (1), PREM14A (1), SC 13D/A (1)

  • Latest filingsAnnual report (10-K) Mar 24, 2022
    Quarterly report (10-Q) Nov 10, 2022
    Proxy statement (DEF 14A) Apr 14, 2022
    Latest 8-K (8-K) Dec 1, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
    SEC EDGAROther events
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45